Definium Therapeutics, Inc. · NASDAQ:DFTX
Avoro Capital Advisors LLC reported a 5.08% stake in Definium Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Avoro Capital Advisors LLC reported a 5.08% stake in Definium Therapeutics, Inc., 5,000,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.08%
- Shares
- 5,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 5.08% | 5,000,000 |
| Behzad Aghazadeh | 5.08% | 5,000,000 |